ebook Munafa Stock Market Course + Intraday & FNO calls  

       

FateTherapeutics FATE full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Fate Therapeutics FATE WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI USA stock exchange

operates under Health Care sector & deals in Biotechnology Biological Products No Diagnostic Substances

Daily price and charts and targets FateTherapeutics

Strong intraday Stock price targets for FateTherapeutics are 2.31 and 2.43

Intraday Target 12.22
Intraday Target 22.28
Intraday Target 32.34
Intraday Target 42.4
Intraday Target 52.46

Daily price and volume Fate Therapeutics

Date Closing Open Range Volume
Mon 14 September 2026 2.34 (1.3%) 2.30 2.28 - 2.40 0.7381 times
Fri 11 September 2026 2.31 (-0.86%) 2.36 2.30 - 2.39 0.8487 times
Thu 10 September 2026 2.33 (-4.51%) 2.42 2.28 - 2.45 0.8587 times
Wed 09 September 2026 2.44 (-2.4%) 2.48 2.42 - 2.52 0.6328 times
Tue 08 September 2026 2.50 (0.81%) 2.45 2.40 - 2.55 2.1928 times
Fri 04 September 2026 2.48 (2.48%) 2.38 2.38 - 2.49 0.699 times
Thu 03 September 2026 2.42 (-1.22%) 2.45 2.40 - 2.51 0.8179 times
Wed 02 September 2026 2.45 (0.82%) 2.43 2.38 - 2.51 1.3936 times
Tue 01 September 2026 2.43 (1.67%) 2.35 2.34 - 2.48 1.1905 times
Mon 31 August 2026 2.39 (-1.65%) 2.40 2.37 - 2.44 0.6279 times
Fri 28 August 2026 2.43 (-4.33%) 2.51 2.41 - 2.53 0.8173 times

 Daily chart FateTherapeutics

Weekly price and charts FateTherapeutics

Strong weekly Stock price targets for FateTherapeutics FATE are 2.31 and 2.43

Weekly Target 12.22
Weekly Target 22.28
Weekly Target 32.34
Weekly Target 42.4
Weekly Target 52.46

Weekly price and volumes for Fate Therapeutics

Date Closing Open Range Volume
Mon 14 September 2026 2.34 (1.3%) 2.30 2.28 - 2.40 0.082 times
Fri 11 September 2026 2.31 (-6.85%) 2.45 2.28 - 2.55 0.5035 times
Fri 04 September 2026 2.48 (2.06%) 2.40 2.34 - 2.51 0.5252 times
Fri 28 August 2026 2.43 (4.29%) 2.34 2.23 - 2.62 0.9004 times
Fri 21 August 2026 2.33 (-9.34%) 2.58 2.32 - 2.79 0.9758 times
Fri 14 August 2026 2.57 (-8.21%) 2.85 2.48 - 2.85 1.0902 times
Fri 07 August 2026 2.80 (14.29%) 2.43 2.37 - 2.88 2.1999 times
Fri 31 July 2026 2.45 (1.66%) 2.49 2.25 - 2.56 0.8443 times
Fri 24 July 2026 2.41 (-13.31%) 2.76 2.40 - 2.89 0.7881 times
Fri 17 July 2026 2.78 (-10.9%) 3.08 2.60 - 3.23 2.0907 times
Fri 10 July 2026 3.12 (6.85%) 2.93 2.82 - 3.19 1.9633 times

 weekly chart FateTherapeutics

Monthly price and charts FateTherapeutics

Strong monthly Stock price targets for FateTherapeutics FATE are 2.18 and 2.45

Monthly Target 12.12
Monthly Target 22.23
Monthly Target 32.39
Monthly Target 42.5
Monthly Target 52.66

Monthly price and volumes Fate Therapeutics

Date Closing Open Range Volume
Mon 14 September 2026 2.34 (-2.09%) 2.35 2.28 - 2.55 0.1827 times
Mon 31 August 2026 2.39 (-2.45%) 2.43 2.23 - 2.88 0.9191 times
Fri 31 July 2026 2.45 (-9.59%) 2.62 2.25 - 3.23 1.2078 times
Tue 30 June 2026 2.71 (-4.58%) 2.75 1.81 - 2.78 2.1634 times
Fri 29 May 2026 2.84 (127.2%) 1.25 1.24 - 2.88 2.1731 times
Thu 30 April 2026 1.25 (4.17%) 1.22 1.13 - 1.45 0.5364 times
Tue 31 March 2026 1.20 (-18.92%) 1.41 1.04 - 1.52 0.644 times
Fri 27 February 2026 1.48 (24.37%) 1.17 1.04 - 1.70 0.7334 times
Fri 30 January 2026 1.19 (21.43%) 0.99 0.97 - 1.36 0.7827 times
Wed 31 December 2025 0.98 (-14.04%) 1.14 0.95 - 1.19 0.6575 times
Fri 28 November 2025 1.14 (-15.56%) 1.24 0.95 - 1.31 0.616 times

 monthly chart FateTherapeutics

Yearly price and charts FateTherapeutics

Strong yearly Stock price targets for FateTherapeutics FATE are 1.66 and 3.92

Yearly Target 1-0.08
Yearly Target 21.13
Yearly Target 32.18
Yearly Target 43.39
Yearly Target 54.44

Yearly price and volumes Fate Therapeutics

Date Closing Open Range Volume
Mon 14 September 2026 2.34 (138.78%) 0.99 0.97 - 3.23 1.0377 times
Wed 31 December 2025 0.98 (-40.61%) 1.68 0.66 - 1.99 1.1885 times
Tue 31 December 2024 1.65 (-55.88%) 3.66 1.55 - 8.83 1.4568 times
Fri 29 December 2023 3.74 (-62.93%) 9.94 1.63 - 11.44 1.5721 times
Fri 30 December 2022 10.09 (-82.76%) 58.62 9.56 - 60.43 0.9417 times
Fri 31 December 2021 58.51 (-35.65%) 91.54 43.60 - 121.16 0.6469 times
Thu 31 December 2020 90.93 (0%) 41.80 41.38 - 103.66 0.1564 times
Tue 15 September 2026 (0%) - 0 times

Indicator Analysis of FateTherapeutics

Tomorrow's movement Prediction of Fate Therapeutics FATE appears to be in downtrend.

But this trend seems to be weakening.

Price is below an important level of 2.42 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Fate Therapeutics FATE made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Tomorrow's movement Prediction of Fate Therapeutics FATE appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.

Munafa value: 50 as on Mon 14 September 2026

This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.

SMA20 is at 3 and price is deviating by 1 points

Upper Bollinger band is at 3 and lower is at 3, while middle bands are at 3 and 3

Price is rising

Price is below 20day SMA

Price is in lower range of bands

Price action analysis of FateTherapeutics (FATE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for FateTherapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for FateTherapeutics in short term and the sell signal is strong.

FateTherapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for FateTherapeutics in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of FateTherapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.42 and FateTherapeutics FATE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the FateTherapeutics FATE stock. Volume based technical analysis of FateTherapeutics FATE stock is negative.

FateTherapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Fate Therapeutics FATE

DMA (daily moving average) of Fate Therapeutics FATE

DMA period DMA value
5 day DMA 2.38
12 day DMA 2.42
20 day DMA 2.46
35 day DMA 2.5
50 day DMA 2.61
100 day DMA 2.33
150 day DMA 1.98
200 day DMA 1.76

EMA (exponential moving average) of Fate Therapeutics FATE

EMA period EMA current EMA prev EMA prev2
5 day EMA2.372.382.42
12 day EMA2.422.432.45
20 day EMA2.462.472.49
35 day EMA2.522.532.54
50 day EMA2.582.592.6

SMA (simple moving average) of Fate Therapeutics FATE

SMA period SMA current SMA prev SMA prev2
5 day SMA2.382.412.43
12 day SMA2.422.442.46
20 day SMA2.462.472.48
35 day SMA2.52.52.51
50 day SMA2.612.622.63
100 day SMA2.332.322.31
150 day SMA1.981.971.96
200 day SMA1.761.751.74

Videos related to: FateTherapeutics FATE full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Hindi Video What Is Needed To Succeed In Stock Markets

FateTherapeutics FATE full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

 

Back to top